Hypohidrosis related to the administration of topiramate to children

Epilepsia

Volumn 42, Issue 10, 2001, Pages 1363-1365

  Arcas, Joaquín ^a   Ferrer, Teresa ^b   Roche, María C ^a   Martínez Bermejo, Antonio ^a,b   López Martín, Valentín ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL INFANTIL LA PAZ   (Spain)

Author keywords

Adverse effects; Epilepsy; Hypohidrosis; Sweat glands; Topiramate

Indexed keywords

CARBAMAZEPINE; CORTICOTROPIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ANHIDROSIS; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG TOLERABILITY; EXERCISE TEST; FOCAL EPILEPSY; HEAT STRESS; HUMAN; INTRACTABLE EPILEPSY; MALE; PRIORITY JOURNAL; SEIZURE; WEST SYNDROME;

ADOLESCENT; ANTICONVULSANTS; CHILD; EPILEPSIES, PARTIAL; EPILEPSY; FEVER; FRUCTOSE; HUMANS; HYPOHIDROSIS; INFANT; MALE; SPASMS, INFANTILE; SWEATING;

EID: 0035168861     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.09201.x     Document Type: Article

References (15)

1. Difficulties in extrapolating from clinical trial data to clinical practice
2. Quality of life of people with epilepsy: A European study
3. Clinical administration of new antiepileptic drugs: An overview of safety and efficacy
4. Effectiveness, tolerability and safety of topiramate in children with partial-onset seizures
5. Sympathetic sudomotor function and aging
6. Sympathetic sudomotor function in diabetic neuropathy
7. The pharmacology of sweating
8. Biology of sweat glands and their disorders, I: Normal sweat gland function
9. The distribution of substance P-, CGRP-, galanin, and ANP-like immunoreactive nerves in human sweat glands
10. Immunohistochemical localization of carbonic anhydrase II and I in eccrine sweat glands from control subjects and patients with cystic fibrosis
11. Topiramate and metabolic acidosis
12. Topiramate and fulminant liver failure
13. Central hyperventilation related to administration of topiramate
14. An overview of the pre-clinical aspects of topiramate: Pharmacology, pharmacokinetics and mechanism of action
15. Oligohidrosis caused by zonisamide